Effect of fengycin, a lipopeptide produced by Bacillus subtilis, on model biomembranes

Biophysical Journal
M DeleuTommy Nylander

Abstract

Fengycin is a biologically active lipopeptide produced by several Bacillus subtilis strains. The lipopeptide is known to develop antifungal activity against filamentous fungi and to have hemolytic activity 40-fold lower than that of surfactin, another lipopeptide produced by B. subtilis. The aim of this work is to use complementary biophysical techniques to reveal the mechanism of membrane perturbation by fengycin. These include: 1), the Langmuir trough technique in combination with Brewster angle microscopy to study the lipopeptide penetration into monolayers; 2), ellipsometry to investigate the adsorption of fengycin onto supported lipid bilayers; 3), differential scanning calorimetry to determine the thermotropic properties of lipid bilayers in the presence of fengycin; and 4), cryogenic transmission electron microscopy, which provides information on the structural organization of the lipid/lipopeptide system. From these experiments, the mechanism of fengycin action appears to be based on a two-state transition controlled by the lipopeptide concentration. One state is the monomeric, not deeply anchored and nonperturbing lipopeptide, and the other state is a buried, aggregated form, which is responsible for membrane leakage a...Continue Reading

References

Aug 23, 1988·Biochemistry·K Simons, G van Meer
Dec 19, 1985·Biochimica Et Biophysica Acta·D Lichtenberg
May 24, 1983·Biochimica Et Biophysica Acta·D LichtenbergE A Dennis
Jun 4, 1993·Journal of Chromatography·H RazafindralamboP Thonart
Oct 29, 1996·Biochimica Et Biophysica Acta·D Marsh
Jun 5, 1997·Nature·K Simons, E Ikonen
Jul 15, 1998·The Journal of Membrane Biology·D A Brown, E London
Nov 25, 1998·Biophysical Journal·U Kragh-HansenJ V Møller
May 13, 1999·Biochimica Et Biophysica Acta·A GrauA Ortiz
Apr 20, 2000·The Journal of Biological Chemistry·D A Brown, E London
May 8, 2000·Advances in Colloid and Interface Science·D Vollhardt, V B Fainerman
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·S S FunariK Beyer
Apr 2, 2003·Advances in Colloid and Interface Science·Gerald Brezesinski, Helmuth Möhwald
Apr 30, 2003·Biophysical Journal·Ana Coutinho, Manuel Prieto
Aug 5, 2003·Biochimica Et Biophysica Acta·Ludger M IckensteinKatarina Edwards
Oct 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Monique DuboisThomas Zemb
Jan 27, 2005·Biochimica Et Biophysica Acta·Hanna P VacklinR K Thomas
Mar 9, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·M EemanY F Dufrêne
Mar 15, 2005·Advances in Colloid and Interface Science·Boris Zhmud, Fredrik Tiberg
Mar 23, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Jan-Willem BenjaminsTommy Nylander
Mar 23, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Hanna P VacklinRobert K Thomas
Jan 3, 2006·Biophysical Journal·Andrey FilippovGöran Lindblom
Mar 9, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Maria C SandströmKatarina Edwards

❮ Previous
Next ❯

Citations

Aug 19, 2009·Analytical and Bioanalytical Chemistry·C SivapathasekaranRamkrishna Sen
Apr 29, 2010·Applied Microbiology and Biotechnology·Ibrahim M BanatRoger Marchant
May 11, 2010·Canadian Journal of Microbiology·Fabrizio RivardoHoward Ceri
Dec 15, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Jonathan R CoronelAntonio Ortiz
Apr 17, 2013·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Mehmet Nail NasirMagali Deleu
Jan 3, 2009·Colloids and Surfaces. B, Biointerfaces·Katherine NottMagali Deleu
May 29, 2014·Medicinal Research Reviews·Stephen A Cochrane, John C Vederas
Nov 21, 2008·Letters in Applied Microbiology·L B HuZ Q Shi
Jul 14, 2010·Journal of Mass Spectrometry : JMS·Ylenia PecciGianna Allegrone
Nov 21, 2015·Biophysical Journal·Sebastian Fiedler, Heiko Heerklotz
Dec 24, 2013·Biochemical and Biophysical Research Communications·Xingliang PanZhiyang Dong
May 7, 2011·Biochimica Et Biophysica Acta·Hiren PatelHeiko Heerklotz
Feb 15, 2011·International Journal of Antimicrobial Agents·Fabrizio RivardoHoward Ceri
Nov 20, 2012·Biochimica Et Biophysica Acta·Magali DeleuMarie-Paule Mingeot-Leclercq
Jan 30, 2015·BioMed Research International·Khem Raj Meena, Shamsher S Kanwar
Feb 9, 2017·Canadian Journal of Microbiology·Rowida MohamedTyler J Avis
Apr 11, 2018·Avian Pathology : Journal of the W.V.P.A·Ar'Quette GrantHyun S Lillehoj
Jul 30, 2019·Molecular Plant Pathology·Romain SchellenbergerStéphan Dorey
Aug 24, 2019·Recent Patents on Biotechnology·Mauro Ezio Eustáquio PiresPaulo Afonso Granjeiro
Sep 8, 2016·Standards in Genomic Sciences·Benjamin J SchofieldPhilip Hugenholtz

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.